Huntington National Bank’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Huntington National Bank’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	1	–	–	﹤0.01%	4291
2025 Q4	$0	Hold	1	–	–	﹤0.01%	4256
2025 Q3	$0	Hold	1	–	–	﹤0.01%	4219
2025 Q2	$0	Hold	1	–	–	﹤0.01%	4251
2025 Q1	$0	Hold	1	–	–	﹤0.01%	4277
2024 Q4	$1	Hold	1	–	–	﹤0.01%	4040
2024 Q3	$1	Hold	1	–	–	﹤0.01%	4032
2024 Q2	$2	Hold	1	–	–	﹤0.01%	3930
2024 Q1	$4	Hold	1	–	–	﹤0.01%	3739
2023 Q4	$3	Buy	+1	New	+$2	﹤0.01%	3670

Huntington National Bank's OMGA Position: Q1 2026 in Review

Huntington National Bank held its Omega Therapeutics, Inc. Common Stock (OMGA) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4291.

Huntington National Bank first reported a position in OMGA in Q4 2023 and has held it in 10 quarters since. The position peaked at $4 in Q1 2024. 1 fund tracked by Wall St. Rank holds OMGA as of Q1 2026.

Huntington National Bank held 1 share of Omega Therapeutics, Inc. Common Stock worth $0 as of Q1 2026.
Huntington National Bank left its Omega Therapeutics, Inc. Common Stock share count unchanged in Q1 2026.
Omega Therapeutics, Inc. Common Stock made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4291 holding.
Huntington National Bank first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2023 and has held it in 10 quarters since.
Huntington National Bank's Omega Therapeutics, Inc. Common Stock position peaked at $4 in Q1 2024.
1 fund tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.